A healthtech site that speaks to clinicians and investors at once
Dual-track healthtech marketing site with clinical proof, investor-ready founder story, and a CMS your team can actually update. Three to five weeks from $2,000.
Who this is for
Healthtech founder (seed to Series A), often with a clinical co-founder and a fundraising deadline, who needs one site that serves two very different buyers.
The pain today
- Site has to speak to clinicians and investors and currently does neither well
- Study results and product updates need dev help to publish
- Founder story and clinical credibility are buried or missing
- Accessibility, privacy, and analytics posture is unclear to partners
- Current site does not survive a 30-second investor skim
The outcome you get
- Dual-track healthtech site in three to five weeks from $2,000
- Clear clinical-credibility section with published evidence and methodology
- Investor-ready founder story and team credentials above the fold
- Self-serve CMS so results, press, and product updates ship without me
- Privacy, accessibility, and analytics configured for regulated partners
Healthtech site strategy — who are you actually talking to
Every healthtech site serves at least two audiences: clinicians or healthcare buyers, and investors. A single homepage that tries to please both usually fails both. The fix is a primary track that matches your current revenue motion, with a second clearly-signposted path for the other audience. If you are selling into health systems, lead with clinical proof and workflow integration. Keep the investor story on a dedicated 'for investors' page. If you are raising first and selling second, flip it. I help you decide this in week one and we build the structure around the decision, not around hope.
Clinical trust signals vs investor-ready signals
Clinicians look for published evidence, clinical advisors, workflow fit, and interoperability. Investors look for team credentials, traction, TAM clarity, and regulatory path. The page furniture is different. Clinicians want methodology and data; investors want logos and growth. I build two pages, not one — both pulling from a shared content library — so each buyer sees what convinces them first. Marketing keeps one set of source material and two tailored views. No duplication, no drift, no founder-mode editing chaos.
CMS choice so non-devs can update study results
The worst healthtech pattern: study results sit in a PDF because publishing a page needs a developer. Fix this in week one. Default stack: Next.js plus Sanity or Payload. Your marketing or clinical lead gets a structured content form for each type of output — study, publication, press release, product update — and ships without touching code. I build the schemas, map the styling, and write a short handoff video. Everything stays consistent; nothing gets stuck in a developer queue.
Pricing and timeline
Starter $2,000 — up to eight pages, your copy, my layout, CMS-ready. Business $5,000 — dual-track site (clinicians + investors), custom content library, study publication flow, evidence page. Corporate $10,000+ — multi-audience, multi-language, partner portal, deep analytics. Three to five weeks start to launch. 14-day money-back guarantee. 1-year bug warranty. 100 percent code ownership under Work Made for Hire. NDA standard. If you are raising, we can scope a launch page first in two weeks while the full site comes together in parallel.
Case: GigEasy — investor-ready MVP in three weeks
At GigEasy I shipped a Barclays and Bain Capital-backed MVP from scratch in 3 weeks, against a ten-week industry norm. That required the same discipline a healthtech launch needs — one focused story, a site and product that survived investor scrutiny, zero time wasted on vanity. Same playbook for healthtech: you pick the essential pages, I build them to a standard both clinicians and investors respect, and we do not ship anything that does not earn its place. The GigEasy demo landed on schedule with zero post-launch fires.
When a generic site is enough vs when you need a product portal
A marketing site is enough when your clinical proof, team, and roadmap carry the message on their own. A product portal becomes worth building when you have real users demoing the product and need a self-serve experience. Portals are Applications-subscription scope, not a fixed-price website. Most healthtech founders ship the marketing site first, raise on it, then move to Applications to build the product portal once there is budget and a roadmap. That sequencing avoids sinking $80k into a portal before product-market fit.
Recent proof
A comparable engagement, delivered and documented.
Built and shipped an investor-ready MVP from scratch
Built the entire technological base and delivered MVP in just 3 weeks, enabling a successful rapid launch and investor demo.
Frequently asked questions
The questions prospects ask before they book.
- Can the site make regulatory claims?
- The site can describe your regulatory status in factual language — 'FDA 510(k) submission in progress,' 'CE mark expected Q3,' 'HIPAA-aware workflows.' It should not make efficacy claims that are not supported by published evidence. I build the structure for claims and disclosures; your legal and regulatory team approves the wording. Most healthtech founders already have a QA/RA advisor who owns this. I work with them directly to land the copy in under two review rounds.
- How do you handle clinical content review?
- Clinical content runs through your clinical co-founder or medical advisor. I do not write medical copy. I build the content schema so every clinical claim has a citation field, a reviewer field, and a last-reviewed date. That gives you an auditable trail when a partner health system asks. Review cycles typically take one to two extra weeks on top of the base timeline. Budget for that and we launch without surprises.
- Is the site HIPAA in-scope?
- The marketing site usually is not, because it collects only name, email, and a general inquiry. If you want patients or clinicians to describe conditions, upload records, or request a specific service through the site, that workflow needs to route through a HIPAA-compliant vendor with a BAA. I build the boundary explicitly — the marketing site stays light, and any clinical intake links out to a compliant form or portal. If you need an integrated portal, that is Applications scope.
- What analytics can we run on a healthtech site?
- Standard web analytics (GA4, Plausible, Vercel Analytics, MS Clarity) are fine because they do not touch PHI. I do not drop session-replay tools on pages where patients might enter clinical information — those tools can capture PHI and trigger BAA obligations. Analytics posture is documented in your privacy policy. If you need de-identified patient journey data, we scope a custom event strategy that keeps PHI out of the analytics pipeline.
- Can you build a site that scales with our fundraising?
- Yes. The Business tier already includes a CMS your team can grow into. As you add investors, case studies, advisors, and press, the schemas handle it without a developer. If you move from seed to Series A and need a full product portal, you move to the Applications subscription at $3,499 a month — the website code stays, and the portal becomes a new surface on the same stack. No rebuild, no starting over.
Ready to start?
Tell me what you need in 60 seconds. Tailored proposal in your inbox within 6 hours.